IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 135 filers reported holding IMMUNOVANT INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $704 | -6.6% | 37,135 | -23.6% | 0.01% | 0.0% |
Q1 2023 | $754 | -99.4% | 48,595 | +113.4% | 0.01% | +200.0% |
Q3 2022 | $127,000 | -89.6% | 22,776 | -92.7% | 0.00% | -86.7% |
Q2 2022 | $1,222,000 | -25.6% | 313,356 | +5.1% | 0.02% | -28.6% |
Q1 2022 | $1,642,000 | -4.1% | 298,070 | +48.3% | 0.02% | +16.7% |
Q4 2021 | $1,713,000 | +47.9% | 201,044 | +50.9% | 0.02% | +12.5% |
Q3 2021 | $1,158,000 | -59.8% | 133,200 | -51.2% | 0.02% | -50.0% |
Q2 2021 | $2,882,000 | +732.9% | 272,717 | +1151.0% | 0.03% | +433.3% |
Q4 2019 | $346,000 | – | 21,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |